The rise in Alzheimer’s disease is a global crisis and a societal grand challenge for the 21st Century. It threatens not only the health of populations globally, but also sustainable economic growth, fiscal policies, and the social fabric of European communities. Alzheimer’s is a case study for how European science, European institutions, and European public-private partnerships can play a leadership role in addressing a global challenge through global collaboration.
The Alzheimer’s CEO Roundtable seeks to provide additional private sector collaboration to complement important efforts already underway in governments, patient groups, universities, and other communities and to catalyze new actions to accelerate the fight against Alzheimer’s.
The four goals of The Global CEO Initiative on Alzheimer’s disease include:
- Develop and issue the comprehensive a Alzheimer’s research agenda
- Identify specific, quantifiable actions that reduce the time, cost, and risk associated with developing therapies for Alzheimer’s disease
- Clarify the fiscal and economic case for addressing Alzheimer’s, and define new global investment models that will increase research and drive innovation in care and care delivery
- Leverage the collective voice of business and government to enhance public engagement, increase the understanding of Alzheimer’s disease, and promote proactive approaches to addressing cognitive health for those who suffer from Alzheimer’s as well as their loved ones
